Last Updated:
Access Report
Name Designation Appointment Date Status
Dipak Rao

Appointed as Director since June 2009

 Director 05-Jun-2009 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Paul Gregory Howes

Appointed as Director since June 2009

 Director 05-Jun-2009 Current
James Goodwin Ham Iii

Appointed as Director since June 2009

 Director 05-Jun-2009 Current

People Timeline

Explore the timeline of key personnel in India Inotek Clinical Research Private Limited's leadership journey.

Contact Details
  • Address B-92 9Th Floorhimalaya House 23 K.G. Marg New Delhi, Na Delhi, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code
  • Country India
  • Website -
Frequently Asked Questions
How can I contact India Inotek Clinical Research Private Limited?
You can contact India Inotek Clinical Research Private Limited through their registered address at B-92 9Th Floorhimalaya House 23 K.G. Marg New Delhi, Na Delhi, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of India Inotek Clinical Research Private Limited?
The current directors of India Inotek Clinical Research Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • DIPAK RAO
  • PAUL GREGORY HOWES
  • JAMES GOODWIN HAM III
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available